mitapivat

FDA Drug Profile — AQVESME, PYRUKYND

Drug Details

Generic Name
mitapivat
Brand Names
AQVESME, PYRUKYND
Application Number
NDA216196
Sponsor
Agios Pharmaceuticals, Inc.
NDC Codes
7
Dosage Forms
TABLET, FILM COATED, KIT
Routes
ORAL
Active Ingredients
MITAPIVAT

Indications and Usage

1 INDICATIONS AND USAGE PYRUKYND is indicated for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency. PYRUKYND is a pyruvate kinase activator indicated for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency. ( 1 )